204 related articles for article (PubMed ID: 36175351)
1. Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review.
Stuursma A; Lanjouw L; Idema DL; de Bock GH; Mourits MJE
J Sex Med; 2022 Dec; 19(12):1778-1789. PubMed ID: 36175351
[TBL] [Abstract][Full Text] [Related]
2. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
[TBL] [Abstract][Full Text] [Related]
3. Mindfulness, cognitive behavioural and behaviour-based therapy for natural and treatment-induced menopausal symptoms: a systematic review and meta-analysis.
van Driel CM; Stuursma A; Schroevers MJ; Mourits MJ; de Bock GH
BJOG; 2019 Feb; 126(3):330-339. PubMed ID: 29542222
[TBL] [Abstract][Full Text] [Related]
4. The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy.
Tucker PE; Bulsara MK; Salfinger SG; Tan JJ; Green H; Cohen PA
Maturitas; 2016 Mar; 85():42-8. PubMed ID: 26857878
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial.
van Driel C; de Bock GH; Schroevers MJ; Mourits MJ
BJOG; 2019 Feb; 126(3):402-411. PubMed ID: 30222235
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women.
Kotz K; Alexander JL; Dennerstein L
J Womens Health (Larchmt); 2006 Oct; 15(8):898-908. PubMed ID: 17087613
[TBL] [Abstract][Full Text] [Related]
8. Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.
Jeffers L; Reid J; Fitzsimons D; Morrison PJ; Dempster M
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD012894. PubMed ID: 31595976
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and sexuality in women.
Dennerstein L; Burrows GD
Clin Endocrinol Metab; 1982 Nov; 11(3):661-79. PubMed ID: 6814799
[TBL] [Abstract][Full Text] [Related]
10. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause.
Nappi RE; Lello S; Melis GB; Albani F; Polatti F; Genazzani AR
Climacteric; 2009 Dec; 12(6):533-40. PubMed ID: 19905905
[TBL] [Abstract][Full Text] [Related]
11. Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
Steenbeek MP; Harmsen MG; Hoogerbrugge N; de Jong MA; Maas AHEM; Prins JB; Bulten J; Teerenstra S; van Bommel MHD; van Doorn HC; Mourits MJE; van Beurden M; Zweemer RP; Gaarenstroom KN; Slangen BFM; Brood-van Zanten MMA; Vos MC; Piek JMJ; van Lonkhuijzen LRCW; Apperloo MJA; Coppus SFPJ; Massuger LFAG; IntHout J; Hermens RPMG; de Hullu JA
JAMA Oncol; 2021 Aug; 7(8):1203-1212. PubMed ID: 34081085
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy after surgery for epithelial ovarian cancer.
Saeaib N; Peeyananjarassri K; Liabsuetrakul T; Buhachat R; Myriokefalitaki E
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012559. PubMed ID: 31989588
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic mastectomy and bilateral salpingo-oophorectomy in patients with breast cancer: a systematic review of postsurgical sexual function and menopausal hormone therapy symptom mitigation.
Morgan O; Belda R; Schnur J; Montgomery G; Parmar S; Chirivella I; Cano A
Sex Med Rev; 2023 Dec; 12(1):3-13. PubMed ID: 37183167
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
15. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clustering of menopausal symptoms in older women by hysterectomy and oophorectomy status.
Kritz-Silverstein D; Goldani Von Mühlen D; Barrett-Connor E
J Womens Health Gend Based Med; 2000 Sep; 9(7):747-55. PubMed ID: 11025867
[TBL] [Abstract][Full Text] [Related]
17. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren JL; Braunstein GD; Simon JA; Casson PR; Buster JE; Redmond GP; Burki RE; Ginsburg ES; Rosen RC; Leiblum SR; Caramelli KE; Mazer NA
N Engl J Med; 2000 Sep; 343(10):682-8. PubMed ID: 10974131
[TBL] [Abstract][Full Text] [Related]
18. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 35831234
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy in naturally and surgically menopausal women.
Panzer C; Guay A
J Sex Med; 2009 Jan; 6(1):8-18; quiz 19-20. PubMed ID: 19170830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
